Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery Desmoglein 3
Path
Created with Sketch.
Go to Desmoglein 3 Normal Tissue Gallery
Go back to Product Page
Adrenal gland- Dsg3 negative adrenocortical adenoma.
Adrenal gland- Dsg3 negative adrenocortical adenoma.
Anal canal- Squamous cell carcinoma with strong Dsg3 immunostaining of tumor cells.
Anal canal- Squamous cell carcinoma with strong Dsg3 immunostaining of tumor cells.
Breast- Dsg3 negative invasive breast cancer of no special type (NST).
Breast- Dsg3 negative invasive breast cancer of no special type (NST).
Breast- Invasive breast cancer of no special type (NST) exhibiting a strong membranous Dsg3 immunostaining of tumor cells.
Breast- Invasive breast cancer of no special type (NST) exhibiting a strong membranous Dsg3 immunostaining of tumor cells.
Colon- Colorectal adenocarcinoma with weak to moderate membranous Dsg3 immunostaining of tumor cells.
Colon- Colorectal adenocarcinoma with weak to moderate membranous Dsg3 immunostaining of tumor cells.
Colon- Dsg3 negative colorectal adenocarcinoma.
Colon- Dsg3 negative colorectal adenocarcinoma.
Esophagus- Squamous cell carcinoma with strong Dsg3 positivity of tumor cells.
Esophagus- Squamous cell carcinoma with strong Dsg3 positivity of tumor cells.
Kidney- Dsg3 negative clear cell renal cell carcinoma.
Kidney- Dsg3 negative clear cell renal cell carcinoma.
Liver- Dsg3 negative hepatocellular carcinoma.
Liver- Dsg3 negative hepatocellular carcinoma.
Lung- Dsg3 negative adenocarcinoma.
Lung- Dsg3 negative adenocarcinoma.
Lung- Squamous cell carcinoma with strong membranous Dsg3 immunostaining of all tumor cells.
Lung- Squamous cell carcinoma with strong membranous Dsg3 immunostaining of all tumor cells.
Lymph node- Dsg3 negative Hodgkin’s lymphoma.
Lymph node- Dsg3 negative Hodgkin’s lymphoma.
Oral cavity- Squamous cell carcinoma with strong predominantly membranous Dsg3 immunostaining of tumor cells.
Oral cavity- Squamous cell carcinoma with strong predominantly membranous Dsg3 immunostaining of tumor cells.
Ovary- Dsg3 negative clear cell carcinoma.
Ovary- Dsg3 negative clear cell carcinoma.
Ovary- Dsg3 negative endometroid carcinoma.
Ovary- Dsg3 negative endometroid carcinoma.
Ovary- Dsg3 negative serous high-grade carcinoma.
Ovary- Dsg3 negative serous high-grade carcinoma.
Pancreas- Dsg3 negative ductal adenocarcinoma.
Pancreas- Dsg3 negative ductal adenocarcinoma.
Penis- Squamous cell carcinoma with intense membranous Dsg3 immunostaining of tumor cells.
Penis- Squamous cell carcinoma with intense membranous Dsg3 immunostaining of tumor cells.
Prostate- Dsg3 negative adenocarcinoma (Gleason 3+3=6).
Prostate- Dsg3 negative adenocarcinoma (Gleason 3+3=6).
Salivary gland- Warthin tumor with strong Dsg3 immunostaining of tumor cells.
Salivary gland- Warthin tumor with strong Dsg3 immunostaining of tumor cells.
Skin- Basal cell carcinoma showing a weak Dsg3 immunostaining of tumor cells.
Skin- Basal cell carcinoma showing a weak Dsg3 immunostaining of tumor cells.
Skin- Dsg3 negative basal cell carcinoma.
Skin- Dsg3 negative basal cell carcinoma.
Skin- Dsg3 negative malignant melanoma.
Skin- Dsg3 negative malignant melanoma.
Skin- Dsg3 negative Merkel cell carcinoma.
Skin- Dsg3 negative Merkel cell carcinoma.
Skin- Squamous cell carcinoma with strong Dsg3 immunostaining of tumor cells.
Skin- Squamous cell carcinoma with strong Dsg3 immunostaining of tumor cells.
Stomach- Dsg3 negative gastric adenocarcinoma.
Stomach- Dsg3 negative gastric adenocarcinoma.
Stomach- Dsg3 negative gastrointestinal stromal tumor (GIST).
Stomach- Dsg3 negative gastrointestinal stromal tumor (GIST).
Stomach- Gastric adenocarcinoma (intestinal type) showing focal weak to moderate membranous Dsg3 immunostaining of tumor cells.
Stomach- Gastric adenocarcinoma (intestinal type) showing focal weak to moderate membranous Dsg3 immunostaining of tumor cells.
Testis- Dsg3 negative seminoma.
Testis- Dsg3 negative seminoma.
Thymus- Thymoma with moderate to strong membranous Dsg3 immunostaining of epithelial tumor cells.
Thymus- Thymoma with moderate to strong membranous Dsg3 immunostaining of epithelial tumor cells.
Thyroid- Dsg3 negative papillary carcinoma.
Thyroid- Dsg3 negative papillary carcinoma.
Urinary bladder- Dsg3 negative muscle-invasive urothelial carcinoma.
Urinary bladder- Dsg3 negative muscle-invasive urothelial carcinoma.
Urinary bladder- Squamous cell carcinoma showing strong membranous Dsg3 immunostaining.
Urinary bladder- Squamous cell carcinoma showing strong membranous Dsg3 immunostaining.
Uterus, cervix- Squamous cell carcinoma with variable membranous Dsg3 immunostaining of tumor cells. Staining is only weak in basal tumor cells.
Uterus, cervix- Squamous cell carcinoma with variable membranous Dsg3 immunostaining of tumor cells. Staining is only weak in basal tumor cells.
Vagina- Squamous cell carcinoma with weak to moderate Dsg3 immunostaining of tumor cells.
Vagina- Squamous cell carcinoma with weak to moderate Dsg3 immunostaining of tumor cells.
Vulva- Squamous cell carcinoma showing a strong, predominantly membranous Dsg3 immunostaining of tumor cells.
Vulva- Squamous cell carcinoma showing a strong, predominantly membranous Dsg3 immunostaining of tumor cells.